We show here that overexpression of p21Cip1 and p19Arf during rhabdomyosarcoma development in a p53-defective system can enhance clonogenicity, motility and metastatic capacity of rhabdomyosarcoma cells. This evidence concerns the gene CDKN2A and rhabdomyosarcoma.